Our findings that NEK10- mutant patients exhibited a significantly better overall survival (p < 0.05), whereas mutations in NEK1 , NEK2 , NEK5 , and NEK9 showed non-significant trends toward improved survival, and mutations in NEK4 and NEK8 showed a trend toward worse survival are consistent with a context‐dependent dual role of NEKs in tumorigenesis.
← all excerpts
Mutational insights and <i>in silico</i> characterization of <i>NEK</i> family kinases in OSCC patients from the Pakistani population.
1
—
—